Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 February 2024 | Story VALENTINO NDABA | Photo SUPPLIED
Dr Jacques Matthee
Dr Jacques Matthee, was recently appointed the new Vice-Dean at the Faculty of Law.

In the dynamic landscape of academia, where traditional methodologies intersect with digital advancements, Dr Jacques Matthee stands out as a beacon of innovation and change. Recently assuming the role of Vice-Dean for Learning, Teaching, Innovation, and Digitalisation at the Faculty of Law, University of the Free State (UFS), Dr Matthee brings with him a profound dedication to knowledge, a passion for transformation, and a clear vision for the future of legal education.

With a distinguished academic background, including qualifications in LLB, LLM, and LLD, Dr Matthee has established himself as an expert in areas such as Legal Pluralism, African Customary Law, Criminal Law, and Medical Law. However, it is not just his credentials that distinguish him; it is his unwavering commitment to the pursuit of knowledge that sets him apart.

Pursuing knowledge: A lifelong passion

Reflecting on his childhood aspirations, Dr Matthee recalls dreaming of becoming a detective – a fascination that eventually led him to the realm of law. Over time, his interest in law deepened, propelling him towards his current position as a leading figure in legal academia. Yet, Dr Matthee’s ambitions extend beyond conventional success. In 2023, he surprised many by participating in his first-ever fitness event, demonstrating a determination to challenge himself beyond the boundaries of his profession. This blend of dedication, discipline, and integrity not only characterises his personal pursuits but also informs his professional endeavours.

Charting new horizons: The Vice-Dean's vision

Assuming the role of Vice-Dean for Learning, Teaching, Innovation, and Digitalisation, Dr Matthee enters uncharted territory. "It is a new position, not only within the faculty but also at UFS," he explains. "There is no model or blueprint to guide us." However, it is precisely this challenge that excites him the most. With autonomy in his role, Dr Matthee sees an opportunity to shape the future of legal education by pioneering initiatives that integrate traditional pedagogy with cutting-edge digital advancements.

"I look forward to the challenge of creating such a blueprint," Dr Matthee remarks. "Moreover, the position will allow me to explore and introduce exciting initiatives that could make a meaningful impact on the future and direction of teaching and learning in the faculty."

For Dr Matthee, the future of legal education lies not only in embracing innovation but also in cultivating an environment where curiosity thrives and knowledge knows no bounds. Under his leadership, the Faculty of Law at UFS is poised to embark on a transformative journey, where learning, teaching, and innovation converge to shape the legal minds of tomorrow.

In Dr Jacques Matthee, the UFS Faculty of Law finds not just a Vice-Dean, but a visionary dedicated to pushing boundaries, challenging norms, and sculpting a future where the pursuit of knowledge knows no limits. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept